Clinical Trials
3 trialsNCT07190300 2026-06-03
TulmiSTAR-02
Novartis
Phase 1/2 Recruiting
NCT04708431 2026-05-19
Androgen Receptor, Implications for Health and Wellbeing: Natural History Study of Individuals With Androgen Insensitivity
National Institutes of Health Clinical Center (CC)
Recruiting
NCT03437941 2026-05-15
Study to Evaluate Exicorilant (CORT125281) in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer
Corcept Therapeutics
Phase 1/2 Terminated